Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$12.88 - $19.47 $198,699 - $300,363
-15,427 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$9.83 - $13.99 $5,121 - $7,288
521 Added 3.5%
15,427 $194,000
Q2 2020

Aug 05, 2020

BUY
$6.75 - $12.89 $2,038 - $3,892
302 Added 2.07%
14,906 $180,000
Q1 2020

May 11, 2020

SELL
$5.8 - $18.56 $113,888 - $364,444
-19,636 Reduced 57.35%
14,604 $112,000
Q4 2019

Feb 13, 2020

BUY
$10.31 - $17.81 $353,014 - $609,814
34,240 New
34,240 $610,000

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $217M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.